Opiant Pharmaceuticals to Report Fourth Quarter 2020 Financial Results and Host Conference Call and Webcast on March 4, 2021
23 February 2021 - 8:01AM
Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a
specialty pharmaceutical company developing medicines for
addictions and drug overdose, today announced it will report
its financial results for the fourth quarter and year ended
December 31, 2020, after the financial markets close
on Thursday March 4, 2021.
The Company’s management team is scheduled to host
a conference call and webcast at 4:30 p.m.
ET on Thursday March 4, 2021. To access the call, please
dial 877-407-0792 in the U.S. or 201-689-8263 outside
the U.S. and provide the conference ID number: 13715395.
To access the live webcast, please go to the investors section of
Opiant’s website at http://ir.opiant.com/. Following the live
webcast, an archived version of the call will be available on the
website.
Thursday March 4 @ 4:30 pm
ET |
Domestic: |
877-407-0792 |
International: |
201-689-8263 |
Conference ID: |
13715395 |
Webcast: |
http://ir.opiant.com/ |
|
|
About Opiant Pharmaceuticals,
Inc.Opiant Pharmaceuticals, Inc., the company that
developed NARCAN® Nasal Spray, is building a
leading franchise of new medicines to combat addictions
and drug overdose.
For more information
visit: www.opiant.com.
Investor Relations Contacts:Ben
AtkinsVP of Corporate Communications and Investor
Relationsbatkins@opiant.com(310) 598-5410
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Apr 2024 to May 2024
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Opiant Pharmaceuticals Inc (NASDAQ): 0 recent articles
More News Articles